On-Demand UPMC Chemotherapy and Biotherapy Course
The On-Demand UPMC Chemotherapy and Biotherapy Course contains the elements of the live four day activity but allows the participant to access the learning on their own schedule. Those enrolled in the course are required to complete all video modules containing lectures from the four-day course. Once all videos have been viewed, complete the evaluation to receive 22.75 continuing education credits. Notify manager to contact course director to schedule the learner course exam for Chemotherapy and Biotherapy on-Demand course. Upon passing the test, with a score of 80% or greater the learner will receive certificate of completion for the activity.
The course components include: Video lecture, course evaluation and chemotherapy and biotherapy course test.
To enroll, choose Register and scroll to the bottom of the page and choose Enroll.
- Discuss the expectations related to class content and the participant’s professional responsibilities
- Discuss the roles of chemotherapy and biotherapy in the treatment of cancer
- Recall the pharmacology of different classes of antineoplastic or supportive therapies
- Recognize side effects and organ toxicities that patients may experience while receiving antineoplastic or supportive therapies
- Discuss management strategies for patients receiving antineoplastic or supportive therapies, including the prevention and treatment of toxicities and side effects
- Describe the safe administration of antineoplastic and supportive therapies
- Identify interventions to prevent chemotherapy errors
- Develop a patient care management plan for a patient receiving antineoplastic therapies
- Identify three resources for oncology healthcare providers to utilize
- Demonstrate that learning has occurred by achieving at least an 80% on the final exam
|Workbook for Lectures||5.44 MB|
|Antineoplastic Therapy Formulas||140.97 KB|
|Case Study Answer Key.pdf||90.28 KB|
|Chemo Homework Presentation 2020.pdf||984.87 KB|
|Comprehensive Chemotherapy and Biological Therapies Course Study Guide.pdf||305.55 KB|
|Comprehensive Chemotherapy and Biological Therapies Course Study Guide - Answer Sheet.pdf||202.46 KB|
|Case study 3-11-2021.pdf||148.46 KB|
Amanda Agnew, PharmD, BCPS, BCOP
Melissa Bastacky, PharmD, BCOP
Thomas G. Boyer, PA-C
Timothy Brenner, PharmD, BCOP
Jaime Kriner, PA-C
Shrina Duggal, PharmD, BCOP
Timothy George, PharmD, BCOP
Gloria Gotaskie, MSN, RN
Jamilyn Kennell, MSN, RN, OCN
Paul Huffman, PharmD
Gerard P. Mascara, PharmD, BCOP
Becky McClelland, MSN-Ed, RN, OCN
Brian Miller, PharmD
Peggy Nikolajski, MSN, CRNP, AOCNP
Alyssa Owens, MPAS, PA-C
Hannah Peterson, PA-C
Brittni Prosdocimo, MSN, RN, BMTCN
Jason Steele, PharmD, BCOP
Courtney Stetor, MPAS, PA-C
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 22.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
The maximum number of hours awarded for this Continuing Nursing Education activity is 22.75 contact hours.
- 22.75 AAPA Category I CME
- 22.75 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 22.75 Attendance